Helix BioPharma (HBP) Competitors C$0.97 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors HBP vs. BCT, IPA, MDNA, SCYB, COM, TH, NVH, COV, ONC, and IGXShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Theratechnologies (TH), Novoheart (NVH), Covalon Technologies (COV), Oncolytics Biotech (ONC), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. BriaCell Therapeutics ImmunoPrecise Antibodies Medicenna Therapeutics Scythian Biosciences 138267 (COM.TO) Theratechnologies Novoheart Covalon Technologies Oncolytics Biotech IntelGenx Technologies Helix BioPharma (TSE:HBP) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings, community ranking and institutional ownership. Is HBP or BCT more profitable? BriaCell Therapeutics' return on equity of 0.00% beat Helix BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A -2,220.62% -279.98% BriaCell Therapeutics N/A N/A N/A Does the media refer more to HBP or BCT? In the previous week, Helix BioPharma's average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score. Company Overall Sentiment Helix BioPharma Neutral BriaCell Therapeutics Neutral Which has stronger valuation and earnings, HBP or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$6.14M-C$0.20-4.85BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Does the MarketBeat Community believe in HBP or BCT? Helix BioPharma received 26 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 68.97% of users gave BriaCell Therapeutics an outperform vote while only 63.46% of users gave Helix BioPharma an outperform vote. CompanyUnderperformOutperformHelix BioPharmaOutperform Votes6663.46% Underperform Votes3836.54% BriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% SummaryHelix BioPharma and BriaCell Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$47.55MC$165.68MC$5.14BC$6.07BDividend Yield1.50%3.64%5.09%5.42%P/E Ratio-4.85115.5190.1326.16Price / SalesN/A18,531.021,116.251,332.85Price / Cash11.3212.8743.1082.30Price / Book-97.008.594.783.07Net Income-C$6.14M-C$20.67MC$120.31MC$295.24M7 Day Performance-3.00%-1.05%-1.92%-2.48%1 Month Performance25.97%174.77%13.65%-0.91%1 Year Performance361.90%134.18%28.34%33.65% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$0.97flatN/AN/AC$47.55MN/A-4.859Gap DownBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownMDNAMedicenna TherapeuticsN/AC$1.72-2.8%N/A+317.1%C$131.46MN/A-4.5320SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AC$2.95-2.6%N/AN/AC$102.19MN/A0.00N/ATHTheratechnologiesN/AC$2.21+2.8%N/A+17.9%C$101.62MC$82.57M-12.28103News CoverageHigh Trading VolumeNVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/ACOVCovalon TechnologiesN/AC$3.49+2.9%N/A+184.0%C$95.63MC$29.20M-87.25N/AONCOncolytics Biotech1.0519 of 5 starsC$1.18flatC$3.50+196.6%-29.6%C$90.70MN/A-3.1129News CoverageHigh Trading VolumeIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Medicenna Therapeutics Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Theratechnologies Competitors Novoheart Competitors Covalon Technologies Competitors Oncolytics Biotech Competitors IntelGenx Technologies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:HBP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
